[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.82.105. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 17, 2007

Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;297(3):261-263. doi:10.1001/jama.297.3.262-a

To the Editor: The clinical trial comparing unfractionated and low-molecular-weight heparin for the treatment of VTE by Dr Kearon and colleagues1 lacks an important component recommended by the CONSORT statement: a justification for the chosen noninferiority margin.2 The authors' assertion of noninferiority of unfractionated heparin is called into question by this omission, combined with the enrollment of fewer patients than planned, as well as recent reports of a trend in favor of low-molecular-weight heparin compared with intravenous unfractionated heparin.3,4

First Page Preview View Large
First page PDF preview
First page PDF preview
×